International News Central
Facebook Tweet Email Link A category-action lawsuit has been filed in opposition to CVS Caremark over its choice to cease covering Zepbound, Eli Lilly’s blockbuster GLP-1 drug to deal with…
Facebook Tweet Email Link The newest outcomes from a trial of a pill kind common GLP-1 drugs supply sufficient data for the Eli Lilly to request international regulatory approval this…
Facebook Tweet Email Link In the primary Phase 3 trial of its once-daily oral GLP-1 pill in people with obesity, drugmaker Eli Lilly stated Thursday that it helped people decrease…
Major insurance changes are coming to GLP-1 drugs for weight loss. Here’s how that could affect patients NCS With information from